Live Breaking News & Updates on Nasdaq Rprx

Stay updated with breaking news from Nasdaq rprx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Overbrook Management Corp Has $6.17 Million Holdings in Royalty Pharma plc (NASDAQ:RPRX)

Overbrook Management Corp lessened its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 26.5% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 219,677 shares of the biopharmaceutical company’s stock after selling 79,035 shares during the period. Royalty […] ....

United States , Lindbrook Capital , Rakuten Securities Inc , Goldman Sachs Group , Exchange Commission , Jpmorgan Chase Co , Eversource Wealth Advisors , Overbrook Management Corp , Royalty Pharma , Free Report , Management Corp , Source Wealth Advisors , Get Free Report , Visit Holdingschannel , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by California Public Employees Retirement System

California Public Employees Retirement System grew its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,136,899 shares of the biopharmaceutical company’s stock after buying an additional 110,768 shares during the […] ....

United States , Goldman Sachs Group , Eversource Wealth Advisors , California Public Employees Retirement System , Exchange Commission , Jpmorgan Chase Co , Lindbrook Capital , Rakuten Securities Inc , Royalty Pharma , Free Report , Public Employees Retirement System , Source Wealth Advisors , Get Free Report , Visit Holdingschannel , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Handelsbanken Fonder AB Cuts Position in Royalty Pharma plc (NASDAQ:RPRX)

Handelsbanken Fonder AB lessened its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 891,918 shares of the biopharmaceutical company’s stock after selling 39,718 shares during the quarter. Handelsbanken Fonder AB’s holdings in Royalty Pharma were worth $25,054,000 as of its most […] ....

United States , Institute For Wealth Management , Holdings Channel , Jpmorgan Chase Co , Securities Exchange Commission , Goldman Sachs Group , Daiwa Securities Group Inc , Lindbrook Capital , Handelsbanken Fonder , Royalty Pharma , Free Report , Wealth Management , Daiwa Securities Group , Securities Group , Get Free Report , Visit Holdingschannel , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Synovus Financial Corp

Synovus Financial Corp boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 26.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,741 shares of the biopharmaceutical company’s stock after purchasing an additional 24,721 shares during the period. Synovus Financial […] ....

United States , Roryb Riggs , Avara Management Ltd , Exchange Commission , Synovus Financial Corp , Securities Exchange Commission , Associates Corp , Goldman Sachs Group , Eversource Wealth Advisors , Jpmorgan Chase Co , Morgan Stanley , Royalty Pharma , Free Report , Financial Corp , Source Wealth Advisors , Financial Advisors , Director Rory , Royalty Pharma Daily , Nasdaq Rprx , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Royalty Pharma plc (NASDAQ:RPRX) Receives Average Recommendation of "Buy" from Analysts

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the four ratings firms that are currently covering the stock, Marketbeat reports. Four research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have issued a report on the stock […] ....

United States , Roryb Riggs , Lindbrook Capital , Royalty Pharma Company Profile , Eversource Wealth Advisors , Securities Exchange Commission , Jpmorgan Chase Co , Morgan Stanley , Goldman Sachs Group , Royalty Pharma , Get Free Report , Director Rory , Exchange Commission , Financial Advisors , Source Wealth Advisors , Get Free , Royalty Pharma Daily , Nasdaq Rprx ,